Biocon commercial rights on biosimilar adalimumab extends to global markets Farhat Nasim8 May 2019 9:45 AM ISTBiocon, under the terms of its global partnership with Mylan for monoclonal antibodies, retains its economic interest in this expanded in-licensing...
Jacobus Pharma wins USFDA approval for Ruzurgi to treat rare autoimmune disorder Medical Dialogues Bureau7 May 2019 9:25 AM ISTThe drug, Ruzurgi, was approved for use in patients aged between 6 and 17, the FDA said Lambert-Eaton myasthenic syndrome, which affects about three...
DOP Order: NPPA refixes retail price of Trilosar 6.25, 12.5 Meghna A Singhania6 May 2019 11:23 AM ISTNew Delhi: Through a recent notification, the government regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail...
Lupin, Zydus Cadila recall products in US; includes BP drug Carvedilol Farhat Nasim6 May 2019 10:00 AM ISTLupin Somerset is recalling 46,700 bottles of Morphine Sulfate extended-release tablets in various strengths due to "failed impurities/degradation...
China war on healthcare costs lure Indian drugmaker Sun Pharma: Report Medical Dialogues Bureau6 May 2019 9:15 AM ISTChina has rolled out an ambitious multi-city bulk procurement program that's driving down prices and providing an opening for Indian manufacturers...
Eli Lilly to present new data on Emgality, Lasmiditan at AAN annual meeting Farhat Nasim5 May 2019 10:00 AM ISTEmgality is also currently under Priority Review by the FDA as an investigational drug for the preventive treatment of episodic cluster headache in...
Cadila Healthcare gets 14 USFDA observations for Moraiya plant Farhat Nasim4 May 2019 10:00 AM ISTThe US Food and Drug Administration (USFDA) inspected the plant from April 22, 2019 to May 3, 2019, Cadila Healthcare said in a regulatory filing.New...
Alembic Pharma gets USFDA approval for Olopatadine Hydrochloride Ophthalmic Solution Farhat Nasim2 May 2019 4:04 PM ISTOlopatadine Hydrochloride Ophthalmic Solution USP, 0.2% is indicated for the treatment of ocular itching associated with allergic conjunctivitis.New...
Sanofi wins USFDA approval to sell dengue vaccine Dengvaxia in parts of US Farhat Nasim2 May 2019 10:00 AM ISTDengvaxia is a live, attenuated vaccine that is administered as three separate injections, with the initial dose followed by two additional shots...
AstraZeneca ties up with Transgene to develop viral immunotherapies Garima2 May 2019 9:25 AM ISTAstraZeneca has been moving deeper into cancer therapy market through wide-ranging deals, including those for immunotherapy and targeted therapy.New...
CDSCO approves Zydus, SIFI pact to launch Intraocular Lenses in India Farhat Nasim30 April 2019 10:15 AM IST"SIFI's innovative IOLs (Intraocular lenses) have been approved by the Indian Central Drugs Standards Control Organisation(CDSCO) (Directorate General...
Cipla gets USFDA nod for Ambrisentan tablets to treat pulmonary arterial hypertension Farhat Nasim30 April 2019 10:00 AM ISTCipla's Ambrisentan tablets 5 mg and 10 mg is AB-rated generic therapeutic equivalent version of Gilead Sciences Inc's Letairis.New Delhi: Drug major...
